IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
55 hedge funds and large institutions have $39.8M invested in Insight Molecular Diagnostics Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 14 increasing their positions, 15 reducing their positions, and 14 closing their positions.
Holders
55
Holders Change
+4
Holders Change %
+7.84%
% of All Funds
1.2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
14
Reduced
15
Closed
14
Calls
$25K
Puts
$9K
Net Calls
+$16K
Net Calls Change
+$16K
Top Buyers
1 |
1
BlackRock
New York
|
$3.87M |
2 |
2
State Street
Boston,
Massachusetts
|
$877K |
3 |
MS
3
Maven Securities
St Helier,
Jersey
|
$550K |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$3.52M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$760K |